173 related articles for article (PubMed ID: 21693462)
1. Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
Noguera O; López-Riquelme N; Rodríguez JC; Belda S; Galiana A; Ruiz-García M; López-García P; Royo G
J Antimicrob Chemother; 2011 Sep; 66(9):2182-4. PubMed ID: 21693462
[No Abstract] [Full Text] [Related]
2. Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
Noguera O; López-Riquelme N; Rodríguez JC; Santibañez M; Alvarez L; Galiana A; Ruiz-García M; López-García P; Royo G
Int J Antimicrob Agents; 2012 Aug; 40(2):189-90. PubMed ID: 22727771
[No Abstract] [Full Text] [Related]
3. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Lautenbach E; Strom BL; Bilker WB; Patel JB; Edelstein PH; Fishman NO
Clin Infect Dis; 2001 Oct; 33(8):1288-94. PubMed ID: 11565067
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study.
Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hsueh PR
Int J Antimicrob Agents; 2010 Sep; 36(3):293-4. PubMed ID: 20598511
[No Abstract] [Full Text] [Related]
5. In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
Netikul T; Leelaporn A; Leelarasmee A; Kiratisin P
Int J Antimicrob Agents; 2010 Jun; 35(6):609-10. PubMed ID: 20189774
[No Abstract] [Full Text] [Related]
6. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
So W; Crandon JL; Nicolau DP
J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
[TBL] [Abstract][Full Text] [Related]
7. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
[TBL] [Abstract][Full Text] [Related]
8. Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City.
Landman D; Babu E; Shah N; Kelly P; Bäcker M; Bratu S; Quale J
J Antimicrob Chemother; 2010 Oct; 65(10):2123-7. PubMed ID: 20667885
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems.
Rodríguez-Martinez JM; Conejo MC; Martínez-Martínez L; Cano ME; Velasco C; Pascual A
Clin Microbiol Infect; 2005 May; 11(5):402-4. PubMed ID: 15819868
[TBL] [Abstract][Full Text] [Related]
10. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
11. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.
Lee K; Lim JK; Yong D; Yum J; Chong Y; Okamoto R; Inoue M
J Clin Microbiol; 2001 Oct; 39(10):3696-9. PubMed ID: 11574594
[TBL] [Abstract][Full Text] [Related]
13. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.
Lautenbach E; Metlay JP; Bilker WB; Edelstein PH; Fishman NO
Clin Infect Dis; 2005 Oct; 41(7):923-9. PubMed ID: 16142655
[TBL] [Abstract][Full Text] [Related]
14. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.
Bolon MK; Wright SB; Gold HS; Carmeli Y
Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181
[TBL] [Abstract][Full Text] [Related]
15. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
17. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
18. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
[TBL] [Abstract][Full Text] [Related]
19. Identification of plasmid-mediated quinolone resistance qnr-like genes in Romanian clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Usein CR; Palade AM; Tatu-Chiţoiu D; Ciontea S; Ceciu S; Nica M; Damian M
Roum Arch Microbiol Immunol; 2009; 68(1):55-7. PubMed ID: 19507629
[TBL] [Abstract][Full Text] [Related]
20. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
